Early Trial Shows Some People with Type 1 Diabetes Can Reduce or Stop Insulin—Here's What We Know

A new clinical trial is exploring whether people with Type 1 diabetes can go without insulin therapy. Researchers emphasize these are early findings, and much more study is needed to understand who might benefit and how safe and effective the approach really is.

News report, corroborated with 3 indexed studies

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

cure researchbeta cellsadvancements

Key takeaways

An early-stage clinical trial has reported that some participants with Type 1 diabetes were able to reduce or stop taking insulin, though this is still very preliminary
This finding does not mean Type 1 diabetes is cured—researchers are studying whether certain treatments can help the body manage blood sugar without insulin for longer periods
More research is underway to understand the long-term safety, who might qualify, and how this approach compares to current diabetes management

What the Trial Found

A new clinical trial has reported early results showing that some people with Type 1 diabetes were able to reduce their insulin doses or stop taking insulin altogether. While this is an encouraging sign, researchers are careful to note that these are preliminary findings from an early-stage study, and a lot more work needs to happen before we understand the full picture.

Important Context: This Is Not a Cure

It's crucial to understand that going off insulin in a trial setting is very different from a cure. People with Type 1 diabetes have an autoimmune condition in which the pancreas can no longer produce insulin. Current research explores whether certain interventions might help reduce the amount of insulin people need—or delay the need for it—but the underlying condition remains.

These early results raise important questions that researchers will need to answer: How long do these effects last? Are they safe long-term? Who is most likely to benefit? What happens if someone stops the treatment? These are the kinds of questions that drive the next phases of clinical research.

What Happens Next

Early clinical trial results like these often spark larger, longer studies to confirm findings and understand safety and durability. Researchers will continue to monitor participants and gather data on whether the ability to reduce or stop insulin lasts over time, and whether the approach works equally well for different groups of people.

If you or a loved one is interested in participating in diabetes research, clinical trials are listed on ClinicalTrials.gov. It's always important to discuss any new treatment or research opportunity with your healthcare team before getting involved.

Evidence label

Origin: nbcnews.com (News report). Evidence: News report, corroborated with 3 indexed studies. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.